Article 3 - CONTROL MEASURES FOR COMMUNICABLE DISEASES AND INFESTATIONS
- Section R9-6-301 - Definitions
- Section R9-6-302 - Local Health Agency Control Measures
- Section R9-6-303 - Isolation, Quarantine, Exclusion, and Other Control Measures
- Section R9-6-304 - Food Establishment Control Measures
- Section R9-6-305 - Control Measures for Multi-drug-resistant Organisms
- Section R9-6-306 - Amebiasis
- Section R9-6-307 - Anaplasmosis
- Section R9-6-308 - Anthrax
- Section R9-6-309 - Arboviral Infection
- Section R9-6-310 - Babesiosis
- Section R9-6-311 - Basidiobolomycosis
- Section R9-6-312 - Botulism
- Section R9-6-313 - Brucellosis
- Section R9-6-314 - Campylobacteriosis
- Section R9-6-315 - Carbapenem-resistant Enterobacteriaceae
- Section R9-6-316 - Chagas Infection and Related Disease (American Trypanosomiasis)
- Section R9-6-317 - Chancroid (Haemophilus ducreyi)
- Section R9-6-318 - Chikungunya
- Section R9-6-319 - Chlamydia trachomatis Infection
- Section R9-6-320 - Cholera
- Section R9-6-321 - Clostridium difficile
- Section R9-6-322 - Coccidioidomycosis (Valley Fever)
- Section R9-6-323 - Colorado Tick Fever
- Section R9-6-324 - Conjunctivitis: Acute
- Section R9-6-325 - Creutzfeldt-Jakob Disease
- Section R9-6-326 - Cryptosporidiosis
- Section R9-6-327 - Cyclospora Infection
- Section R9-6-328 - Cysticercosis
- Section R9-6-329 - Dengue
- Section R9-6-330 - Diarrhea, Nausea, or Vomiting
- Section R9-6-331 - Diphtheria
- Section R9-6-332 - Ehrlichiosis
- Section R9-6-333 - Emerging or Exotic Disease
- Section R9-6-334 - Encephalitis, Viral or Parasitic
- Section R9-6-335 - Escherichia coli, Shiga Toxin-producing
- Section R9-6-336 - Giardiasis
- Section R9-6-337 - Glanders
- Section R9-6-338 - Gonorrhea
- Section R9-6-339 - Haemophilus influenzae: Invasive Disease
- Section R9-6-340 - Hansen's Disease (Leprosy)
- Section R9-6-341 - Hantavirus Infection
- Section R9-6-342 - Hemolytic Uremic Syndrome
- Section R9-6-343 - Hepatitis A
- Section R9-6-344 - Hepatitis B and Hepatitis D
- Section R9-6-345 - Hepatitis C
- Section R9-6-346 - Hepatitis E
- Section R9-6-347 - HIV Infection and Related Disease
- Section R9-6-348 - Influenza-Associated Mortality in a Child
- Section R9-6-349 - Legionellosis (Legionnaires' Disease)
- Section R9-6-350 - Leptospirosis
- Section R9-6-351 - Listeriosis
- Section R9-6-352 - Lyme Disease
- Section R9-6-353 - Lymphocytic Choriomeningitis
- Section R9-6-354 - Malaria
- Section R9-6-355 - Measles (Rubeola)
- Section R9-6-356 - Melioidosis
- Section R9-6-357 - Meningococcal Invasive Disease
- Section R9-6-358 - Methicillin-resistant Staphylococcus aureus (MRSA)
- Section R9-6-359 - Mumps
- Section R9-6-360 - Norovirus
- Section R9-6-361 - Novel Coronavirus (e.g., SARS or MERS)
- Section R9-6-362 - Pediculosis (Lice Infestation)
- Section R9-6-363 - Pertussis (Whooping Cough)
- Section R9-6-364 - Plague
- Section R9-6-365 - Poliomyelitis (Paralytic or Non-paralytic)
- Section R9-6-366 - Psittacosis (Ornithosis)
- Section R9-6-367 - Q Fever
- Section R9-6-368 - Rabies in a Human
- Section R9-6-369 - Relapsing Fever (Borreliosis)
- Section R9-6-370 - Respiratory Disease in a Health Care Institution or Correctional Facility
- Section R9-6-371 - Rubella (German Measles)
- Section R9-6-372 - Rubella Syndrome, Congenital
- Section R9-6-373 - Salmonellosis
- Section R9-6-374 - Scabies
- Section R9-6-375 - Shigellosis
- Section R9-6-376 - Smallpox
- Section R9-6-377 - Spotted Fever Rickettsiosis (e.g., Rocky Mountain Spotted Fever)
- Section R9-6-378 - Streptococcal Group A Infection
- Section R9-6-379 - Streptococcal Group B Invasive Infection in an Infant Younger Than 90 Days of Age
- Section R9-6-380 - Streptococcus pneumoniae Invasive Infection
- Section R9-6-381 - Syphilis
- Section R9-6-382 - Taeniasis
- Section R9-6-383 - Tetanus
- Section R9-6-384 - Toxic Shock Syndrome
- Section R9-6-385 - Trichinosis
- Section R9-6-386 - Tuberculosis
- Section R9-6-387 - Tularemia
- Section R9-6-388 - Typhoid Fever
- Section R9-6-389 - Typhus Fever
- Section R9-6-390 - Vaccinia-related Adverse Event
- Section R9-6-391 - Vancomycin-Resistant or Vancomycin-Intermediate Staphylococcus aureus
- Section R9-6-392 - Varicella (Chickenpox)
- Section R9-6-393 - Vibrio Infection
- Section R9-6-394 - Viral Hemorrhagic Fever
- Section R9-6-395 - West Nile Virus Infection
- Section R9-6-396 - Yellow Fever
- Section R9-6-397 - Yersiniosis (Enteropathogenic Yersinia)
- Section R9-6-398 - Zika Virus Infection
- Exhibit III-A - [REPEALED]
- Exhibit III-B - [REPEALED]
- Exhibit III-C - [REPEALED]
- Exhibit III-D - [REPEALED]
- Exhibit III-E - [REPEALED]
- Exhibit III-F - [REPEALED]
- Exhibit III-G - [REPEALED]
- Exhibit III-H - [REPEALED]
- Exhibit III-I - [REPEALED]
- Exhibit III-J - [REPEALED]
- Exhibit III-K - [REPEALED]
- Exhibit III-L - [REPEALED]
- Exhibit III-M - [REPEALED]
- Exhibit III-N - [REPEALED]